bibliographic entry 2492540 [be/2492540]
https://w3id.org/oc/corpus/be/2492540

is a
content
  • Rosenstock, J, Vico, M, Wei, L, Salsali, A, List, JF. Effects of dapagliflozin, an SGLT2 inhibitor, on HbA, 1c, body weight, and hypoglycemia risk in patients with type 2 diabetes inadequately controlled on pioglitazone monotherapy, Diabetes Care, 2012, 35, 7, 1473, 1478, PMID: 22446170
references